Titlebook: Meningiomas; Comprehensive Strate Jennifer Moliterno,Antonio Omuro Book 2020 Springer Nature Switzerland AG 2020 intraventricular.cranio-ce

連續(xù)不斷

書目名稱Meningiomas影響因子(影響力)




書目名稱Meningiomas影響因子(影響力)學科排名




書目名稱Meningiomas網(wǎng)絡公開度




書目名稱Meningiomas網(wǎng)絡公開度學科排名




書目名稱Meningiomas被引頻次




書目名稱Meningiomas被引頻次學科排名




書目名稱Meningiomas年度引用




書目名稱Meningiomas年度引用學科排名




書目名稱Meningiomas讀者反饋




書目名稱Meningiomas讀者反饋學科排名

大都市

Radiographic Assessment of Meningiomasindings in these patients. For the majority of patients, standard imaging techniques of CT and MRI can reliably diagnose a meningioma as the differential diagnosis includes much rarer entities that often are suspected more on the basis of the clinical history. Even though one can reliably suspect a

合同

The Genomic Landscape of Meningiomasd until now (Ostrom et al. Neuro Oncol 30(suppl_4):iv1–86, 2018). Recent studies have defined the genomic landscape of these tumors, identifying somatic driver mutations in several genes in approximately 80% of sporadic meningiomas, categorizing them into six distinct molecular subgroups with import

預測

擔心

foodstuff

Endoscopic and Minimally Invasive Meningioma Surgeryosurgery has become a popular option as a means of achieving ideal neurosurgical results by either using natural corridors or creating corridors to access the pathology. Skull base meningiomas, in selected cases, are ideal pathologies for these techniques, which can offer an alternative approach wit

META

RODE

Radiation Therapy for Low Grade Meningiomasvage, and/or palliative treatment. In selected patient cohorts, definitive radiotherapy has a local control rate comparable to surgery. Although surgical resection is often the preferred treatment option if available, benign meningioma frequently grows in confined spaces such as the base of skull, c

Radiculopathy

Low Grade Tumor Recurrence and Management of More Aggressive Meningiomasorbidity and a poor prognosis due to the need for repeated increasingly aggressive surgery and the absence of robust alternative or adjuvant therapies. This chapter explores the known natural history for patients with aggressive meningioma, before presenting the current evidence for management optio

ineluctable